Galera Therapeutics, Inc. and Obsidian Therapeutics
Obsidian Therapeutics completed mergers with Galera Therapeutics and others on August 3, 2026.
Company-confirmed: reported in the company's own SEC filing
Latest update Aug 3, 2026, 9:08 PM ET
- ✓Announced
- ✓Pending
- ✓Completed
Acquirer
Obsidian TherapeuticsOBXTarget
Galera Therapeutics, Inc.Not US-listed- Deal value
- Not disclosed
- the filing states none
- Offer
- Not disclosed
- Premium
- N/A
- Shown only for a signed all-cash price per share
- Expected close
- Not disclosed
- merger
Share prices around the disclosure
Daily closes, each set to 100 on the first day shown. The dashed lines mark the session that first reflects each public event.
How the shares moved
| Company | Window | Move | S&P 500 same window | Since |
|---|---|---|---|---|
| OBX | Not available: the closing prices around the disclosure are missing | N/A | N/A | N/A |
These are changes in closing prices between a reference close and a measurement close. They do not show that the deal caused the move. For an all-stock or mixed deal, an acquirer's move can reflect the terms themselves.
Timeline
Completed · Completed
Obsidian Therapeutics completed mergers with Galera Therapeutics and others on August 3, 2026.
Obsidian Therapeutics, Inc. completed the mergers pursuant to the Agreement and Plan of Merger dated April 14, 2026. The mergers involved Obsidian Therapeutics Sub, Inc., Legacy Obsidian, Galera Therapeutics, Inc., and Gazelle Merger Subsidiary, Inc.
“Emerging growth company ☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Explanatory Note On August 3 …”
SEC filing accepted Aug 3, 2026, 9:08 PM ET · event dated Aug 3, 2026 · Form 8-K 0001193125-26-330810 on sec.gov
What this means
- What was reported
- Obsidian Therapeutics completed mergers with Galera Therapeutics and others on August 3, 2026.
- Terms the company disclosed
- Value: Not disclosed. Offer per share: not disclosed. Consideration: stock. Anything not listed was not stated in the filing and is not estimated here.
- What comes next
- The filing says the transaction has been completed.
- How the stock moved
- A defined window cannot be measured: the closing prices around the disclosure are not available.
Sources are SEC filings, linked above; the quoted passages are copied from them. Times are US Eastern. If a company later amends or updates a transaction, this page adds a new event and keeps the earlier ones. This is information, not investment advice. All M&A activity